A recent feature in Nature focuses on the various ways industry and academia hope to automate and industrialise Synthetic Biology, including SynbiCITE's upcoming DNA Foundry.

The SynbiCITE Foundry, which will be first Synthetic Biology DNA Foundry available for commercial use in Europe, will provide automated end-to-end design, construction and validation of synthetic biologic components using a suite of state-of-the-art robotic equipment.

The Foundry will provide synthetic biology manufacturing capabilities and training to organisations with innovative ways of using synthetic biology but without the facilities to develop them further.